Filing step-change
PANCM · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-21 · Evidence medium
Panacea Life Sciences (PANCM) reported a 1.82% gross margin in its latest quarterly update, marking a significant turnaround from the -41.67% reported in the previous quarter.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 1.82 % | -41.67 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -41.67 % | -35.33 | ▼ |
Cite this
Source: Samhati filing step-change for PANCM (2026-10). Observation: Panacea Life Sciences (PANCM) reported a 1.82% gross margin in its latest quarterly update, marking a significant turnaround from the -41.67% reported in the previous quarter. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/pancm/q/2026-10
Other periods